van Gorp, Dennis A.M. http://orcid.org/0000-0002-5546-0798
van der Hiele, Karin
Heerings, Marco A.P.
Jongen, Peter J.
van der Klink, Jac J.L.
Reneman, Michiel F.
Arnoldus, Edo P.J.
Beenakker, Ernesto A.C.
van Eijk, Jeroen J.J.
Frequin, Stephan T.F.M.
de Gans, Koen
Hoitsma, Elske
Mostert, Jop P.
Verhagen, Wim I.M.
Zemel, Désirée
Visser, Leo H.
Middelkoop, Huub A.M.
Funding for this research was provided by:
ZonMw (TOP Grant, project number:842003003)
Dutch National Multiple Sclerosis Foundation
Teva Pharmaceutical Industries
Article History
Received: 19 February 2019
Accepted: 27 June 2019
First Online: 19 July 2019
Compliance with ethical standards
: The MS@Work study was approved by the Medical Ethical Committee Brabant (NL43098.008.12 1307; date of approval: 12-02-2014) and the Board of Directors of the participating MS outpatient clinics. All subjects provided written informed consent. The study was performed in agreement with the Declaration of Helsinki [CitationRef removed].
: MH, HM, JvdK, MR, EB and KdG have nothing to disclose. DvG received honoraria for presentation from Sanofi Genzyme. KvdH received honoraria for consultancies, presentations and advisory boards from Sanofi Genzyme and Merck. PJ received honoraria from Bayer, Merck and Teva for contributions to symposia as a speaker or for educational or consultancy activities. EA received honoraria for lectures and honoraria for advisory boards from Teva, Merck, Sanofi Genzyme, Biogen and Novartis. JvE received honoraria for lectures and honoraria for advisory boards from Teva, Merck, Sanofi Genzyme, Biogen, Roche and Novartis. SF received honoraria for lectures, grants for research and advisory boards from Teva, Merck, Sanofi Genzyme, Biogen, Novartis and Roche. EH received honoraria for lectures, travel grants and honoraria for advisory boards from Novartis, Teva, Roche, Merck, Sanofi Genzyme, Biogen and Bayer. JM received personal fees from Novartis, Merck, Sanofi Genzyme and Teva. WV received honoraria for lectures from Biogen and Merck, reimbursement for hospitality from Biogen, Teva, Sanofi Genzyme and Merck, and honoraria for advisory boards from Merck. DZ received honoraria for advisory boards from Novartis, Merck, Sanofi Genzyme and Biogen. LV received honoraria for lectures, grants for research and honoraria for advisory boards from Sanofi Genzyme, Merck, Novartis and Teva.
: The funding sources had no role in the study design, data collection, data analysis, data interpretation, report writing or decision to submit the article for publication.